Centric Wealth Management Abb Vie Inc. Transaction History

Centric Wealth Management

$383 Million
Q3 2024

A detailed history of Centric Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Centric Wealth Management holds 9,748 shares of ABBV stock, worth $1.71 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

9,748

Previous 9,807 0.6%

Holding current value

$1.71 Million

Previous $1.68 Million 14.45%

% of portfolio

0.5%

Previous 0.51%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $9,666 - $11,760	-59 Reduced 0.6%	9,748 $1.93 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $36,685 - $42,840	237 Added 2.48%	9,807 $1.68 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $65,366 - $74,478	409 Added 4.46%	9,570 $1.74 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $50,224 - $56,564	365 Added 4.15%	9,161 $1.42 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $56,241 - $65,107	421 Added 5.03%	8,796 $1.31 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $20,141 - $25,064	152 Added 1.85%	8,375 $1.13 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $60,591 - $69,780	419 Added 5.37%	8,223 $1.31 Million
Q4 2022 Jan 04, 2023	SELL	$138.31 - $165.87 $26,555 - $31,847	-192 Reduced 2.4%	7,804 $0
Q3 2022 Oct 05, 2022	SELL	$134.21 - $153.93 $7,649 - $8,774	-57 Reduced 0.71%	7,996 $1.07 Million
Q2 2022 Jul 06, 2022	BUY	$137.62 - $174.96 $105,829 - $134,544	769 Added 10.56%	8,053 $1.23 Million
Q1 2022 Apr 05, 2022	SELL	$131.98 - $163.75 $10,822 - $13,427	-82 Reduced 1.11%	7,284 $1.18 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $81,646 - $103,306	760 Added 11.5%	7,366 $997,000
Q3 2021 Oct 06, 2021	BUY	$106.4 - $120.78 $43,198 - $49,036	406 Added 6.55%	6,606 $713,000
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $403,690 - $449,734	-3,837 Reduced 38.23%	6,200 $698,000
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $14,424 - $15,879	-141 Reduced 1.39%	10,037 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $306,425 - $413,706	3,807 Added 59.76%	10,178 $1.09 Million
Q3 2020 Oct 05, 2020	SELL	$85.91 - $100.83 $326,114 - $382,750	-3,796 Reduced 37.34%	6,371 $460,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $278,512 - $372,691	3,796 Added 59.58%	10,167 $998,000
Q1 2020 Apr 08, 2020	SELL	$64.5 - $97.79 $29,799 - $45,178	-462 Reduced 6.76%	6,371 $460,000
Q4 2019 Jan 06, 2020	BUY	$72.13 - $90.25 $33,324 - $41,695	462 Added 7.25%	6,833 $605,000
Q3 2019 Oct 03, 2019	BUY	$62.98 - $75.72 $201,410 - $242,152	3,198 Added 100.79%	6,371 $460,000
Q2 2019 Jul 08, 2019	SELL	$65.7 - $83.98 $722 - $923	-11 Reduced 0.35%	3,173 $231,000
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $41,038 - $48,300	532 Added 20.06%	3,184 $257,000
Q4 2018 Mar 19, 2019	BUY	$77.85 - $96.01 $206,458 - $254,618	2,652 New	2,652 $245,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.

Account

Centric Wealth Management Abb Vie Inc. Transaction History